These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8282499)

  • 1. The clotting issue: etiologic factors in thromboembolism. I. Chemistry, pharmacology, and toxicity of angiographic contrast agents.
    Dawson P
    Invest Radiol; 1993 Nov; 28 Suppl 5():S25-30. PubMed ID: 8282499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clotting issue: etiologic factors in thromboembolism. II. Clinical considerations.
    Dawson P; Cousins C; Bradshaw A
    Invest Radiol; 1993 Nov; 28 Suppl 5():S31-6; discussion S37-8. PubMed ID: 8282500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
    Barrett BJ; Parfrey PS; Vavasour HM; O'Dea F; Kent G; Stone E
    N Engl J Med; 1992 Feb; 326(7):431-6. PubMed ID: 1732770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: evolution and strategies for use.
    McClennan BL
    AJR Am J Roentgenol; 1990 Aug; 155(2):225-33. PubMed ID: 2115244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodinated radiographic contrast media: comparison of low-osmolar with conventional ionic agents [corrected].
    Rubin JD; Cohan RH
    Curr Opin Radiol; 1991 Oct; 3(5):637-45. PubMed ID: 1931499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of intravascular low-osmolality contrast agents.
    Swanson DP; Thrall JH; Shetty PC
    Clin Pharm; 1986 Nov; 5(11):877-91. PubMed ID: 3780159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal tolerance of iodinated low osmolality contrast agents. Clinical and experimental aspects].
    Deray G; Dubois M; Bellin MF; Grellet J; Jacobs C
    J Radiol; 1990; 71(6-7):439-44. PubMed ID: 2254874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolic problems in angiography.
    Dawson P
    Semin Hematol; 1991 Oct; 28(4 Suppl 7):31-7; discussion 38-41. PubMed ID: 1822609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative thrombotic risk of two contrast agents in coronary angiography].
    Wolff F; Zupan M; Klero de Rosbo P; Wiesel ML; Grunebaum L; Cazenave JP; Brechenmacher C
    Ann Radiol (Paris); 1994; 37(6):435-9. PubMed ID: 7702336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results using a nonionic contrast medium--a report of clinical experiences].
    Hruby W; Stellamor K
    Rontgenblatter; 1987 Mar; 40(3):73-7. PubMed ID: 3576085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization.
    Biancardi M; Cimminiello C; Toschi V; Schiavina G; Regalia F; Casolo F; Bonfardeci G
    Semin Thromb Hemost; 1996; 22 Suppl 1():61-5. PubMed ID: 8807731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contrast media in venous digital angiography: ionic or non-ionic?].
    Stacul F; Magnaldi S; Pozzi-Mucelli R; Muner G; Dalla Palma L
    Radiol Med; 1986 Nov; 72(11):815-22. PubMed ID: 3786845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics and tolerance of roentgen contrast media].
    Schmiedel E
    Rontgenblatter; 1987 Jan; 40(1):1-8. PubMed ID: 3547606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of low-osmolality contrast media in thromboembolic complications: scanning electron microscopy study.
    Casalini E
    Radiology; 1992 Jun; 183(3):741-4. PubMed ID: 1584930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.